SeaSpine Holdings Corp
SPNEDelisted Jan 5, 2023- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001637761
SeaSpine Holdings Corp was delisted on Jan 5, 2023; its insiders filed their last Form 4 on Jan 9, 2023; 110 institutions reported holding it in 13F filings for Q4 2022, worth $212.6M in total; no superinvestor held it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 1:47 PM ET
Revenue flow, FY2021
Where the revenue went in FY2021, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2021: $54.3M (28.4% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 10, 2022 | Jan 11, 2021 | Jan 7, 2020 | Jan 7, 2019 | Jan 8, 2018 |
| Revenue | $191.5M | $154.3M | $159.1M | $143.4M | $131.8M |
| Cost of revenue | $76.9M | $56.8M | $58.0M | $56.0M | $51.8M |
| Gross profit | $114.6M | $97.5M | $101.1M | $87.5M | $80.0M |
| Research and development | $22.0M | $16.3M | $15.1M | $12.1M | $12.2M |
| Selling, general and administrative | $42.9M | $35.9M | $33.6M | $105.4M | $97.3M |
| Operating income | -$61.0M | -$43.4M | -$39.2M | -$33.1M | -$32.7M |
| Income tax | -$1.10M | $218.0K | $356.0K | $129.0K | -$118.0K |
| Net income | -$54.3M | -$43.2M | -$39.3M | -$33.5M | -$32.1M |
| Margins and growth | |||||
| Gross margin | 59.9% | 63.2% | 63.6% | 61.0% | 60.7% |
| Operating margin | -31.9% | -28.1% | -24.7% | -23.1% | -24.8% |
| Net margin | -28.4% | -28.0% | -24.7% | -23.4% | -24.4% |
| Revenue growth, year over year | +24.0% | −3.0% | +10.9% | +8.8% | +2.3% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 10, 2022 | Jan 11, 2021 | Jan 7, 2020 | Jan 7, 2019 | Jan 8, 2018 |
| Cash and equivalents | $83.1M | $76.8M | $20.2M | $24.2M | $10.8M |
| Short-term investments | – | – | $0 | $29.8M | – |
| Accounts receivable | $36.2M | $26.2M | $24.9M | $20.3M | $21.9M |
| Inventory | $72.3M | $54.0M | $47.2M | $42.7M | $41.7M |
| Total current assets | $196.0M | $160.9M | $96.2M | $120.1M | $76.4M |
| Property, plant and equipment | $46.9M | $31.4M | $25.8M | $22.6M | $22.1M |
| Goodwill | $84.6M | – | – | – | – |
| Intangible assets | $42.1M | $13.9M | $19.2M | $28.7M | $35.2M |
| Total assets | $377.3M | $214.4M | $141.7M | $172.3M | $134.5M |
| Short-term debt | $0 | $1.11M | – | – | $0 |
| Total current liabilities | $53.0M | $30.7M | $30.5M | $26.5M | $23.2M |
| Long-term debt | $0 | $5.06M | – | – | – |
| Total liabilities | $64.9M | $42.7M | $32.0M | $30.3M | $28.8M |
| Shareholders' equity | $312.4M | $171.7M | $109.8M | $142.1M | $105.7M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jan 10, 2022 | Jan 11, 2021 | Jan 7, 2020 | Jan 7, 2019 | Jan 8, 2018 |
| Operating cash flow | -$33.5M | -$24.6M | -$20.3M | -$12.6M | -$8.62M |
| Capital expenditures | $26.0M | $16.1M | $12.8M | $8.35M | $7.45M |
| Free cash flow | -$59.6M | -$40.7M | -$33.1M | -$20.9M | -$16.1M |
| Depreciation and amortization | $13.9M | $10.7M | $10.3M | $10.7M | $10.9M |
| Stock-based compensation | $11.9M | $10.4M | $7.81M | $5.80M | $6.07M |
| Investing cash flow | -$55.4M | -$17.0M | $17.2M | -$38.1M | -$7.65M |
| Financing cash flow | $95.5M | $98.1M | -$829.0K | $64.2M | $12.0M |
| Net change in cash | $6.29M | $56.6M | -$4.03M | $13.4M | -$3.78M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 6.2% | 6.7% | 4.9% | 4.0% | 4.6% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 31, 2022 | 37.2M | +2.1% | SEC |
| Aug 1, 2022 | 37.2M | +2.2% | SEC |
| May 5, 2022 | 36.8M | +11.0% | SEC |
| Mar 7, 2022 | 36.8M | +31.7% | SEC |
| Nov 1, 2021 | 36.4M | +31.9% | SEC |
| Aug 2, 2021 | 36.4M | +32.3% | SEC |
| Apr 29, 2021 | 33.2M | +21.7% | SEC |
| Feb 26, 2021 | 27.9M | +2.6% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.